Hospitals Management Press Releases | Healthcare Industry Press Releases

Hyundai Hope On Wheels Presents Roswell Park Comprehensive Cancer Center With $100,000 Hyundai Impact Award Grant To Support Pediatric Cancer Research

16 July 2019

BUFFALO, N.Y., July 16, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers, announces a

Ambrx to receive milestone payment from Bristol-Myers Squibb for the initiation of Phase 1 Clinical Trial of a long-acting Relaxin derivative

16 July 2019

SAN DIEGO, July 16, 2019 /PRNewswire/ -- Ambrx Inc. today announced that Bristol-Myers Squibb Company ("BMS") has initiated a phase I clinical trial to evaluate the safety, pharmacokinetics and pharmacodynamics of long-acting Relaxin for the potential treatment of heart failure ("HF"). Long-acting Relaxin is an investigational biologic produced using Ambrx' pro

South Florida Sinus and Allergy Center offers premier ENT treatments at their two convenient South Florida locations

16 July 2019

FORT LAUDERDALE, Fla., July 16, 2019 /PRNewswire/ -- With locations in both Plantation and Fort Lauderdale Florida, South Florida Sinus and Allergy Center provides expert care and treatment for those patients suffering from sinus, allergy, snoring, and sleep disorders.

REAL Radiology in 7th Year of Sustainable Success as Teleradiology Provider

16 July 2019

OMAHA, Neb., July 16, 2019 /PRNewswire/ -- REAL Radiology, LLC (NE) is setting the standard for sustainable growth and continued patient-care excellence in the high-demand industry of teleradiology.The global teleradiology market is predicted to reach an all-time high both in market value and demand, according to a recently published

Soliton Announces Submission for IRB Approval of Pivotal Cellulite Trial Protocol

16 July 2019

HOUSTON, July 16, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that the company has submitted its pivotal cellu

Cardinal Health Appoints Stephen Mason To Lead Medical Segment

16 July 2019

DUBLIN, Ohio, July 16, 2019 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced that Stephen Mason, President of the company's Cardinal Health at-Home Solutions business, has been promoted to Chief Executive Officer of Cardinal Health's Medical segment. Mr. Mason will succeed Jon Giacomin, who will

First-Ever Analysis of U.S. Physician Interest in Telemedicine

16 July 2019

SAN FRANCISCO, July 16, 2019 /PRNewswire/ -- Doximity, the professional medical network, today published the first comprehensive

Astellas and Seattle Genetics Announce Submission of Biologics License Application to FDA for Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer

16 July 2019

TOKYO and BOTHELL, Wash., July 16, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa

Digital therapeutics leader Biofourmis to take part in pioneering heart failure research with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI)

16 July 2019

BOSTON, July 16, 2019 /PRNewswire/ -- Biofourmis, a fast-growing global leader in digital therapeutics, has entered a research partnership with the Yale University-May

Medicomp Systems Awarded Patent for Intelligent Filtering of Clinical Data

16 July 2019

WASHINGTON, July 16, 2019 /PRNewswire/ -- Medicomp Systems, a physician-driven provider of clinically contextual patient data solutions, announced today that the United States Patent